Skip to main content

Table 2 Participant’s demographic characteristics (n=23)

From: Feasibility and acceptability of transcutaneous tibial nerve stimulation for the treatment of bladder storage symptoms among people with multiple sclerosis

Category Variable Participants completed the study (20): n (%) Participants lost to follow (3): n (%)
Gender Female 14 (70%) 2 (66.67%)
Male 6 (30%) 1 (33.33%)
Age 18–24 - -
25–34 - -
35–44 6 (30%) 2 (66.67%)
45–54 6 (30%) 1 (33.33%)
55–64 6 (30%) -
65–74 1 (5%) -
75–84 - -
85 or older 1 (5%) -
Marital status Single 2 (10%) 2 (66.67%)
Married 17 (85%) 1 (33.33%)
Widowed - -
Divorced 1 (5%) -
Separated - -
MS type RR MS 12 (60%) 2 (66.67%)
PP MS 5 (25%) 1 (33.33%)
SP MS 3 (15%) -
PR MS - -
MS diagnosis in years 1–5 2 (10%) -
6–10 8 (40%) 1 (33.33%)
11–15 3 (15%) 2 (66.67%)
16–20 3 (15%) -
21–25 2 (10%) -
26–30 1 (5%) -
31–35 - -
36–40 - -
41–45 1 (5%) -
LUTSs main Urgency 16 (80%) 3 (100%)
Frequency 13 (65%) 2 (66.67%)
Nocturia 12 (60%) 1 (33.33%)
Urge incontinence 6 (30%) 1 (33.33%)
Terminal dribbles 4 (20%) -
Hesitancy 5 (25%) -
Feeling of incomplete bladder emptying 8 (40%) 1 (33.33%)
Urinary incontinence 5 (25%) 2 (66.67%)
Double void 4 (20%) 1 (33.33%)
LUTSs in years 1–5 6 (30%) 1 (33.33%)
6–10 9 (45%) -
11–15 3 (15%) 2 (66.67%)
16–20 1 (5%) -
21–25 1 (5%) -
Previous TX None 4 (20%) 1 (33.33%)
Pharmacologic 7 (35%) 1 (33.33%)
Non-pharmacologic:   
Exercises 3 (15%) 1 (33.33%)
Nerve stimulation with another treatment (Exercise and/or Catheterization) 3 (15%) -
Behavioural 3 (15%) -
Current TX None 6 (30%) 2 (66.67%)
Pharmacologic 9 (45%) 1 (33.33%)
Pharmacologic with Catheterization 2 (10%) -
Non-pharmacologic:
Exercises 2 (10%) -
Nerve stimulation - -
Behavioural 1 (5%) -
Prophylactic Yes 3 (15%) -
No 17 (85%) 3 (100%)
Comorbidities None 8 (40%) 1 (33.33 %)
Thyroid related issues 2 (10%) 1 (33.33%)
Hypertension 1 (5%) 1 (33.33%)
Reynolds syndrome 1 (5%)  
Cancer 1 (5%) -
Foot drop/mobility 2 (10%) -
Migraine 1 (5%) 1 (33.33%)
hearing impairment 1 (5%) -
Bowel related issues/duodenal ulcer 3 (15%) -
PDDS-Mobility (0) Normal 3 (15%) -
(1) Mild disability 1 (5%)  
(2) Moderate disability 3 (15%) 1 (33.33%)
(3) Gait disability 2 (10%)  
(4) Early cane 3 (15%)  
(5) Late cane 4 (20%) 1 (33.33%)
(6) Bilateral support 3 (15%)  
(7) Wheelchair 1 (5%) 1 (33.33%)
(8) Bedridden -  
  1. MS multiple sclerosis, RR relapsing–remitting, SP secondary progressive, PP primary progressive, PR progressive relapsing, LUTSs lower urinary tract symptoms, PDDS Patient Determined Disease Step